Dafna Capital Management LLC Assembly Biosciences, Inc. Transaction History

Dafna Capital Management LLC

  • $390 Million
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 16, 2021
SELL
$4.87 - $17.29 $173,240 - $615,057
-35,573 Closed
0 $0
Q4 2019

Feb 14, 2020
SELL
$8.36 - $23.81 $125,399 - $357,150
-15,000 Reduced 29.66%
35,573 $728,000
Q4 2018

Feb 14, 2019
BUY
$19.05 - $36.45 $760,095 - $1.45 Million
39,900 Added 373.84%
50,573 $1.14 Million
Q3 2018

Nov 14, 2018
BUY
$34.41 - $44.23 $367,257 - $472,066
10,673 New
10,673 $396,000

Others Institutions Holding ASMB

# of Institutions
1
Shares Held
16.3K
Call Options Held
0
Put Options Held
0
View Full List

About ASSEMBLY BIOSCIENCES, INC.

ASMB Quotes by TradingView
  • Ticker ASMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,436,900
  • Market Cap $822M
  • Description
  • Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...
More about ASMB
Track This Portfolio

Track Dafna Capital Management LLC Portfolio

Follow Dafna Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dafna Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email